NetworkNewsBreaks – BriaCell Therapeutics Corp.
Post# of 69
BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, is currently developing a personalized immunotherapy drug to treat advanced breast cancer. A recent article further discussing the company reads, “Based on its research results, the company is developing a second immunotherapy drug, Bria-OTS, an off-the-shelf personalized treatment that’s expected to be effective for 90 percent of the advanced breast cancer patient population. Bria-OTS is expected to go to clinical trials in 2019. … BriaCell Therapeutics Corp., based in Berkeley, California, and headquartered in Vancouver, British Columbia, is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer